Australia Biotechnology & Medical Research

Telix Pharmaceuticals Ltd (TLX)

Track

The most recent insider trading activity at Telix Pharmaceuticals Ltd occurred on April 29, 2026, when MD & Group CEO Christian Behrenbruch purchased 33,435 shares. This followed a purchase of 34,500 shares by the same executive on April 28, 2026. These transactions represent the latest buying activity recorded for the company.
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Telix Pharmaceuticals Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 29 Apr 2026
Value US$740,893.06 | Price 424.64 | Shares 95,325 (-26.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-04-29 B Purchase
Behrenbruch Christian

MD & Group CEO

Executive Director
95,325 -26.1%
424.64
US$740,893 		95,325 -26.1% 424.64 US$740,893
2026-05-06 2026-04-28 B Purchase
Behrenbruch Christian

MD & Group CEO

Executive Director
17,232 -48.9%
225.02
US$2,781,841 		17,232 -48.9% 225.02 US$2,781,841
2024-01-22 2024-01-18 B Purchase Dr Christian Behrenbruch Director
1,426
467.76
A$2,333,354 		1,426 467.76 A$2,333,354
2023-06-02 2023-05-30 B Purchase Dr Christian Behrenbruch Director
120,268
2.97
A$356,739 		120,268 2.97 A$356,739
2023-03-17 2023-03-16 B Purchase Tiffany Olson Director
51,305
6.69
A$343,385 		51,305 6.69 A$343,385
2022-12-15 2022-12-12 B Purchase Tiffany Olson Director
10,930
6.70
A$73,256 		10,930 6.70 A$73,256
2022-02-03 2022-02-03 B Purchase Dr Christian Behrenbruch Director
400,000
1.09
A$436,000 		400,000 1.09 A$436,000
2022-01-31 2022-01-27 S Sale Dr Christian Behrenbruch Director
2,000,000
7.70
A$15,400,000 		2,000,000 7.70 A$15,400,000
2022-01-31 2022-01-27 S Sale Dr Andreas Kluge Director
2,000,000
7.70
A$15,400,000 		2,000,000 7.70 A$15,400,000
Explore more

More insider trading research around Telix Pharmaceuticals Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Asia-Pacific